It is well known that patients suffering from COPD are subject to co-morbidities, e.g. lung cancer and cardiovascular disease, which are associated with elevated plasma concentrations of YKL-40 and increased mortality[5,6,16,44]. This evidence concerns the gene CHI3L1 and lung cancer.